CMPS
HEALTHCARECompass Pathways Plc
AI Insight
What's Moving CMPS Today?
No stock-specific AI insight has been generated for CMPS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.59$14.76
$13.13
Fundamentals
Market Cap$1.7B
P/E Ratio—
EPS$-3.14
Dividend Yield—
Dividend / Share—
ROE-68.5%
Profit Margin—
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding134.9M
CMPS News
24 articles- To Wall Street, psychedelics biotechs are more teammates than rivalsBiopharmadive·Jun 24, 2026
- Compass Pathways IPO to Begin Trading 18th September on Nasdaq: CMPSPsychedelic Alpha·Jun 16, 2026
- Is COMPASS Pathways plc (CMPS) A Good Stock To Buy Now?Yahoo Finance·Jun 11, 2026
- Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire·Jun 5, 2026
- Is COMPASS Pathways (CMPS) Quietly Recalibrating Its Commercialization Strategy With This Board Appointment?Yahoo Finance·Jun 2, 2026
- FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidateYahoo Finance·Jun 2, 2026
- Compass Pathways Elects Kathleen Tregoning to Board of DirectorsYahoo Finance·May 28, 2026
- Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026Yahoo Finance·May 26, 2026
- COMPASS Pathways (CMPS) Is Up 13.9% After Swinging From Loss To Q1 2026 Profit - What's ChangedSimply Wall Street·May 24, 2026
- Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 WinsMarketbeat·May 21, 2026
- This Psychedelics Stock Just Keeps Getting Hotter; Why Shares Bypassed A Profit-Taking ZoneYahoo Finance·May 18, 2026
- Assessing COMPASS Pathways (CMPS) Valuation After Strong Q1 2026 Earnings And Key FDA MilestonesYahoo Finance·May 15, 2026
- Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026Yahoo Finance·May 14, 2026
- Compass Pathways PLC (CMPS) Q1 2026 Earnings Call Highlights: Promising Advances in ...Yahoo Finance·May 13, 2026
- Transcript: Compass Pathways Q1 2026 Earnings Conference CallYahoo Finance·May 13, 2026
- Here's Why This Psychedelics Stock Just Took A Trip To A Two-Year HighYahoo Finance·May 13, 2026
- Compass (CMPS) Q1 2026 Earnings TranscriptMotley Fool·May 13, 2026
- Compass Pathways shares rise on Q1 results, accelerated FDA reviewProactive Investors·May 13, 2026
- Compass Pathways Q1 Earnings Call HighlightsMarketbeat·May 13, 2026
- Compass Pathways jumps after earnings beat and accelerated FDA review progress (CMPS)Advfn·May 13, 2026
- Compass Pathways Announces First Quarter 2026 Financial Results and Business HighlightsYahoo Finance·May 13, 2026
- Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026Yahoo Finance·May 6, 2026
- These 3 Psychedelic Stocks Activated After Trump’s Executive OrderInvesting.com·Apr 27, 2026
- The Psychedelic Revolution in Mental HealthcareThe Motley Fool·Apr 17, 2026
All 24 articles loaded
Price Data
Open$12.74
Previous Close$12.65
Day High$13.50
Day Low$12.69
52 Week High$14.76
52 Week Low$2.59
52-Week Range
$2.59$14.76
$13.13
Fundamentals
Market Cap$1.7B
P/E Ratio—
EPS$-3.14
Dividend Yield—
Dividend / Share—
ROE-68.5%
Profit Margin—
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding134.9M
About Compass Pathways Plc
COMPASS Pathways plc is a mental health care company in the United Kingdom and the United States. The company is headquartered in Cheshire, the United Kingdom.
HEALTHCAREMEDICAL CARE FACILITIES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL CARE FACILITIES
CIK—
Composite FIGI—
Share Class FIGI—